CLINICAL AND IMMUNOLOGICAL CHANGES IN TREATMENT OF ADENOMYOSIS IN PATIENTS WITH INFERTILITY

In: Kubanskij nauchnyj medicinskij vestnik · 2017 · pp. 37–44 · doi:10.25207/1608-6228-2017-24-5-37-44 · W2772090279
article OA: diamond CC0 ⤵ 4 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

This study assessed changes in L-selectin, neopterin, and interleukin-6 in adenomyosis patients with infertility and found L-selectin useful for monitoring therapy effectiveness, with gestagens showing better normalization.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08

This paper studied 49 infertile women with adenomyosis to determine how adhesion molecules (L-selectin, neopterin, and interleukin-6) change over the course of therapy, using ELISA and assessing adenomyosis symptoms by a VAS scale. The authors formed three groups (two adenomyosis-associated infertility groups and a control group) and found that L-selectin showed statistically significant pre- vs post-treatment differences with a reported correlation coefficient (R=0.584), which they describe as having diagnostic significance for monitoring treatment effectiveness. They report that gestagens were associated with normalization of L-selectin and reduced VAS intensity of dysmenorrhea and dyspareunia compared with another group, while adenomyosis was not accompanied by a substantial increase in neopterin or IL-6 production; the caveat is that the paper focuses on these circulating markers rather than direct tissue or mechanistic measures. Relevance to endometriosis: adenomyosis is explicitly framed within the paper’s immunologic context (with citations about endometriosis and adenomyosis immune-related markers), though the study’s main focus is adenomyois-associated infertility treatment monitoring via adhesion molecules.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Aim . The aim of this study was to asses changes of adhesion molecules (L-selectin, neopterin and interleukin-6) in patients with adenomyosis-related infertility during the therapy. Materials and methods. 49 patients with infertility caused by adenomyosis were examined and divided into 3 clinical groups: 1 group – 26 patients (35,1%) and 2 group – 23 patients (31,1%) with adenomyosis-associated infertility; 3 group (control) – 25 patients (33,8%). Adhesion molecules detection was performed by enzyme immunoassay (EIA). Visual evaluation scale was used for estimating of clinical aspects of adenomyosis. Results. The diagnostic utility of L-selectin for monitoring the adenomyosis therapy effectiveness was shown. The difference between L-selectin levels before and after treatment was statistically significant, the correlation coefficient (R) reached 0,584. The gestagens application is preferable due to reliable normalization of L-selectin levels and decrease in intensity of algomenorrhea (in the 1st group – 1,3 times less, than in 2nd group) and dyspareunia (in the 1st group – 2,2 times less, than in the 2nd group) on visual evaluation scale. Conclusions. Adenomyosis not accompanied by a significant increase in the production of systematic inflammatory response markers (neopterin and IL-6), the increase of adhesion molecules (L-selectin) indicates the imbalance of endothelial-thrombocyte-leukocyte interaction.

My notes (saved in your browser only)

Condition tags

adenomyosisdyspareuniainfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (8)

Cited by (4)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK